SPACs are back, thanks to Wall Street's mega-IPO frenzy

SPAC activity is rebounding, with 44 announced SPAC mergers worth $36.9 billion this year versus 33 deals worth $15 billion at this point last year. U.S. SPAC issuance has also accelerated, with 145 blank-check companies going public in 2025 and another 107 listed through June 15, 2026, as capital rotates toward smaller issuers facing competition from mega-IPOs. The article suggests sectors such as energy, defense, critical minerals, nuclear, space and crypto could benefit from SPACs as a faster route to market.

Analysis

The tradeable implication is not that SPACs are “back,” but that capital scarcity at the small-cap end of the IPO market is temporarily improving. When mega-deals monopolize roadshow bandwidth and index/ETF allocations, smaller issuers face a worse clearing price in traditional IPOs; SPACs become a liquidity backdoor for companies that can’t afford to wait for a clean tape. That favors sponsors with distribution and balance-sheet credibility, while weak SPAC teams and pre-revenue story stocks should still struggle to clear financing on acceptable terms.

Second-order winners are the adjacent service providers: underwriters, PIPE allocators, legal advisors, and exchange/liquidity venues that benefit from deal velocity rather than deal size. The more interesting macro angle is the sector mix: energy transition infrastructure, defense/critical minerals, and crypto-adjacent names are precisely the sectors where public-market valuation dispersion is widest and milestone risk is hard for generalist IPO buyers to underwrite. If the IPO calendar stays crowded, expect more “valuation negotiation” to shift from the public market to private-room SPAC pricing.

The main risk is that redemption rates reassert themselves if public-market volatility spikes or if one high-profile SPAC de-SPAC stumbles early. This is a months-long setup, not a days-long catalyst: the pipeline can be visible now, but closing risk only resolves as mergers announce and PIPEs syndicate. A reversal would likely come from a sharp correction in mega-IPO sentiment or a regulatory/earnings disappointment that causes investors to pull back from all new issues simultaneously.

Contrarian view: the current enthusiasm may be partly a timing arbitrage rather than a durable regime shift. If mega-IPOs overdeliver and absorb capital without damaging aftermarket performance, smaller issuers may find that investors are still willing to buy them directly, reducing SPAC’s edge. In that case, the best expression is not broad SPAC beta, but selective sponsor exposure and a short against low-quality vehicles likely to rely on heavy redemptions and promotional economics.

Key Decisions for Investors

• Long the highest-quality SPAC sponsors/issuers with credible sector pipelines over the next 3-6 months; prefer names with proven PIPE access and cash-rich merger targets, avoid low-float promo-heavy vehicles where redemptions can destroy the deal.
• Pair trade: long defensively funded SPAC-adjacent financials/advisory beneficiaries vs. short the weakest blank-check shells with limited time to close; the long side should benefit from rising deal velocity while the short side faces liquidation overhang and redemption risk.
• Tactically buy a basket of sector beneficiaries likely to use SPACs as a backdoor to public markets—defense, critical minerals, nuclear, crypto infrastructure—on pullbacks; target 6-12 month horizon where valuation rerating can occur before broad IPO saturation dissipates.
• Use options to express downside in low-quality de-SPAC exposure: buy puts or put spreads on names trading as ‘story stocks’ with no near-term cash-flow visibility; if redemption rates stay elevated, these are the most vulnerable to post-close multiple compression.
• If mega-IPO flow stalls or first-day performance deteriorates, fade the SPAC rebound quickly and rotate back to traditional IPO winners; the regime is fragile and can unwind within 2-4 weeks if investor appetite broadens away from marquee deals.